Attached files

file filename
S-1 - FORM S-1 - Shangri-La Tibetan Pharmaceuticals, Inc.ds1.htm
EX-5.2 - EXHIBIT 5.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex52.htm
EX-1.1 - EXHIBIT 1.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex11.htm
EX-5.1 - EXHIBIT 5.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex51.htm
EX-3.I.2 - EXHIBIT 3(I)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i2.htm
EX-21.1 - EXHIBIT 21.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex211.htm
EX-23.1 - EXHIBIT 23.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex231.htm
EX-10.1 - EXHIBIT 10.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex101.htm
EX-10.2 - EXHIBIT 10.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex102.htm
EX-10.6 - EXHIBIT 10.6 - Shangri-La Tibetan Pharmaceuticals, Inc.dex106.htm
EX-10.3 - EXHIBIT 10.3 - Shangri-La Tibetan Pharmaceuticals, Inc.dex103.htm
EX-10.8 - EXHIBIT 10.8 - Shangri-La Tibetan Pharmaceuticals, Inc.dex108.htm
EX-10.5 - EXHIBIT 10.5 - Shangri-La Tibetan Pharmaceuticals, Inc.dex105.htm
EX-99.2 - EXHIBIT 99.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex992.htm
EX-3.I.1 - EXHIBIT 3(I)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i1.htm
EX-99.1 - EXHIBIT 99.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex991.htm
EX-10.7 - EXHIBIT 10.7 - Shangri-La Tibetan Pharmaceuticals, Inc.dex107.htm
EX-10.4 - EXHIBIT 10.4 - Shangri-La Tibetan Pharmaceuticals, Inc.dex104.htm
EX-10.15 - EXHIBIT 10.15 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1015.htm
EX-10.16 - EXHIBIT 10.16 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1016.htm
EX-10.14 - EXHIBIT 10.14 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1014.htm
EX-10.17 - EXHIBIT 10.17 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1017.htm
EX-10.18 - EXHIBIT 10.18 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1018.htm
EX-10.12 - EXHIBIT 10.12 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1012.htm
EX-3.II.2 - EXHIBIT 3(II)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii2.htm
EX-10.19 - EXHIBIT 10.19 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1019.htm
EX-10.13 - EXHIBIT 10.13 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1013.htm
EX-10.10 - EXHIBIT 10.10 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1010.htm
EX-3.II.1 - EXHIBIT 3(II)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii1.htm
EX-10.11 - EXHIBIT 10.11 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1011.htm

Exhibit 10.9

Translation of Medicinal Material Procurement Contract

Party A (Purchaser): Yunnan Shangri-La Tibetan Pharmaceutical Group Limited

Party B (Supplier): Chun Sheng

 

Product’s Name

   Spec    Unit    Quantity    Unit
Price
   Value
(RMB)
   Procurement Period    Memo

sal—Ammoniac

      kg    1235    74.75    92,317.06    09.1.1-12.31   

Fructus Hippophais

      kg    6450    201.77    1,301,397.07    09.1.1-12.31   

HgS

      kg    1266    313.21    396,527.69    09.1.1-12.31   

Barbary Wolfberry Fruit

      kg    3136    44.71    140,213.71    09.1.1-12.31   

Weeds Fruit

      kg    3198    41.11    131,458.68    09.1.1-12.31   

Bright Salt

      kg    1244    33.5    41,677.19    09.1.1-12.31   

Aconitum naviculare

      kg    3213    390.54    1,254,820.90    09.1.1-12.31   

Chinese Eaglewood

      kg    5105    1383.88    10,882,670.11    09.1.1-12.31   

Cardamon amomum

      kg    1714    162.12    447,098.21    09.1.1-12.31   

The Aggregate Value: RMB 14,688,180.62

The Procurement Place: Yunnan Shangri-La Tibetan Medicine Group Co., Ltd.

Date of Delivery: Delivery within 20 days upon the signature of the Contract

Payment Method: Party A shall make payment of all the accounts payable within 10 days upon the entry of products in the warehouse and Party B shall draw the accounts receivable by presentation of the warehouse voucher.

Quality Standard: State Standard

Package: Polypropylene (PP) Knitted Bag or cloth bag free of any damage.

Quality Requirements by Party B: The products shall comply with the state quality standards as well as the agreed quality standard bases on the said quality standards; Packing Sound

Quality Requirements agreed by Both Parties: The Tibetan medicinal materials standard under the administration authorities of the Ministry of Public Health shall be executed.

Liability of Breach: The breached party shall make the compensation for the non-breach party by the amount equivalent to 30% of the aggregate value of the contract herein.

This contract is in duplicate and shall be effective upon both parties’ signature, seal, and putting one’s fingerprint.

Party A: Yunnan Shangri-La Tibetan Pharmaceutical Group Limited

Authorized Representative: Hong Yu (Signature)

Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (Seal)

Signature Date: Jan 5, 2009

Party B: Chun Sheng

Authorized Representative: Chun Sheng (Signature):

Signature Date: Jan 5, 2009